Empagliflozin as a new management strategy on outcomes in patients with type 2 diabetes mellitus

Patients with type 2 diabetes mellitus have an increased risk of cardiovascular (CV) complications. Although hyperglycaemia contributes to the pathogenesis of atherosclerosis and heart failure in these patients, glucose-lowering strategies did not have a significant effect on reducing CV risk, parti...

Full description

Saved in:
Bibliographic Details
Main Authors: Vladimir V. Salukhov, Tatiana Y. Demidova
Format: article
Language:EN
RU
Published: Endocrinology Research Centre 2016
Subjects:
Online Access:https://doaj.org/article/df96db84249147979cbed089b1755da3
Tags: Add Tag
No Tags, Be the first to tag this record!